The year 2022 marked a significant period for Gilead Sciences as it expanded its product portfolio to encompass a broader range of medical conditions
Palmer SC, Mavridis D, Nicolucci A, Johnson DW, Tonelli M, Craig JC, et al
Semaglutide use and weight loss Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that Three brand names for semaglutide have been approved by the Food and Drug Administration (FDA) for different purposes: Wegovy: FDA-approved for weight loss and reducing the risk of cardiovascular disease
Choosing between IR and XR comes down to lifestyle fit: IR suits people who want flexible dosing control or medication-free evenings, while XR is better for those with long, structured days or who struggle to remember multiple doses
It requires frequent testing of eye pressure, monitoring of visual field loss, and optic nerve evaluations